First FDA-approved CAR-T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma

Continue Reading

Research Grant Roundup

October 31, 2017 | City of Hope

Review the latest City of Hope grant awardees.

Prehistoric Virus May Hold Secret to Fighting Certain Types of Cancer

October 25, 2017 | Katie Neith

City of Hope researchers have found a link between a type of ancient RNA and a tumor suppressing gene.

Core Connection: Electron Microscopy

October 23, 2017 | Katie Neith

At City of Hope’s Electron Microscopy Core Facility, researchers can take sharper, closer looks at the structural elements that form the human body at the nanoscale.

History of Hope: Susumu Ohno

October 23, 2017 | Katie Neith

In 1952, a young researcher named Susumu Ohno came to City of Hope. Though he was only a research associate at the time, his research would soon make waves in the scientific community.

First FDA-approved CAR-T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma

Preclinical CMV Vaccine Shows Promise

October 18, 2017 | Letisia Marquez

A group of researchers in City of Hope’s Department of Experimental Therapeutics and Cal Tech may be one step closer to developing the first CMV vaccine for commercial use.

TGen Spotlight: New Study Tackles Sports-Related Concussions

October 16, 2017 | City of Hope

TGen-Riddell partnership results could help future studies lead to advanced methods of injury and disease detection

Oncologist George Somlo Named Director of Pharmaceutical Initiatives

October 16, 2017 | City of Hope

George Somlo, M.D., an internationally known breast cancer and hematology researcher at City of Hope, has been named director of pharmaceutical initiatives at City of Hope.

Load More